Loading clinical trials...
Loading clinical trials...
Glutaminergic Agents for Cocaine Abuse
The purpose of this study is to evaluate glutaminergic agents for cocaine abuse.
Age
18 - 45 years
Sex
ALL
Healthy Volunteers
No
VA Connecticut Healthcare System
New Haven, Connecticut, United States
Start Date
September 1, 1994
Primary Completion Date
August 1, 1999
Completion Date
August 1, 1999
Last Updated
April 25, 2017
Nimodipine
DRUG
Lead Sponsor
Yale University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03606473